Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Multivitamin wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
8 of 12 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
8 of 15 studies with measurable effects showed benefit.
Top outcomes
1 serving daily (as directed on label, typically 1-2 tablets/capsules)
With breakfast, With lunch (if GI sensitive)
Capsule or softgel
500-2000mg daily for lipid effects; 50-500mg for general health
With food (reduces flush), Evening for lipid effects, Split doses for high amounts
Immediate-release niacin (nicotinic acid)
Therapeutic niacin doses far exceed multivitamin contributions. The primary interaction concern is additive hepatotoxicity risk when combining high-dose niacin (especially extended-release) with multivitamins containing additional hepatotoxic-risk nutrients (vitamin A, iron). SAMe depletion may reduce methylation capacity.
At therapeutic niacin doses (500mg+), the multivitamin niacin content is negligible. The clinical concern is avoiding additional hepatotoxic supplements (excess vitamin A, iron) concurrent with therapeutic niacin. Monitor liver function tests every 3–6 months with therapeutic niacin use. Ensure adequate methyl donor support (B12, folate, choline) to compensate for niacin methylation demand.
3-6 months
4-8 weeks
2-6 weeks
6-12 weeks
4-8 weeks
4-8 weeks
30-60 minutes after dose
Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS
The American Journal of Clinical Nutrition (2024) · Meta analysis · n=5765
Multivitamin-mineral supplementation significantly improved global cognition vs placebo (pooled meta-analysis)
Multivitamin Supplementation Improves Memory in Older Adults: A Randomized Clinical Trial
The American Journal of Clinical Nutrition (2023) · Rct · n=3562
Daily multivitamin supplementation for 3 years significantly improved immediate and delayed recall memory
Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial
Alzheimer's & Dementia (2023) · Rct · n=2262
Multivitamin-mineral supplementation (not cocoa extract) drove significant cognitive improvements in COSMOS-Mind
Niacin for primary and secondary prevention of cardiovascular events
The Cochrane database of systematic reviews (2017) · Meta analysis · n=39195
Participants randomised to niacin were more likely to discontinue treatment due to side effects than participants randomised to control group (RR 2.17, 95% CI 1.70 to 2.77; participants = 33,539; studies = 17; I2 = 77%; moderate-quality evidence).
Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials
Atherosclerosis (2025) · Meta analysis · n=145314
Among available LLTs, PCSK9mAbs, inclisiran, CETPi, and niacin significantly decreased Lp(a) levels.
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Nature medicine (2024) · Meta analysis
Lastly, treatment with physiological levels of 4PY, but not its structural isomer 2PY, induced expression of VCAM-1 and leukocyte adherence to vascular endothelium in mice.
Based on COSMOS trials (n=5765) showing equivalent of 2.0 years cognitive decline prevention. Effects most pronounced in those with cardiovascular disease. Study duration was 3 years. Effectiveness reflects conservative interpretation of memory and global cognition improvements.
Based on multiple meta-analyses showing HDL increases. Higher doses increase discontinuation rates due to side effects (RR 2.17). Immediate-release forms have better lipid effects but more flushing.
AI-estimated from published studies. Interpret as directional guidance.
Multivitamin has a higher evidence score (6/10 vs 6/10) and wins in 2 of 3 categories.
For reduce inflammation, Niacin has a higher relevance score (85 vs 50).
Caution: Therapeutic niacin doses far exceed multivitamin contributions. The primary interaction concern is additive hepatotoxicity risk when combining high-dose niacin (especially extended-release) with multivitamins containing additional hepatotoxic-risk nutrients (vitamin A, iron). SAMe depletion may reduce methylation capacity. At therapeutic niacin doses (500mg+), the multivitamin niacin content is negligible. The clinical concern is avoiding additional hepatotoxic supplements (excess vitamin A, iron) concurrent with therapeutic niacin. Monitor liver function tests every 3–6 months with therapeutic niacin use. Ensure adequate methyl donor support (B12, folate, choline) to compensate for niacin methylation demand. Always consult a healthcare provider before combining these supplements.